By Phuong Nguyen and Yantoultra Ngui

HANOI/SINGAPORE (Reuters) -Vietnam-founded biotechnology firm Gene Solutions plans to raise $100 million through a pre-IPO round and a potential listing as soon as 2026, capitalising on growing demand for genetic diagnostics and a regional revival in initial public listings, the company and its lead investor Mekong Capital said.

The company, which offers prenatal and cancer screenings using Next-Generation Sequencing and AI, plans to raise up to $50 million in the pre-IPO and another $50 million at the listing in either Hong Kong or Singapore, its Chief Financial Officer Keng Hsu told Reuters.

China International Capital Corp is acting as the adviser for the pre-IPO round, Hsu added. CICC did not immediately respond to a request for comment.

Chris F

See Full Page